ArticleInternational ophthalmology2025
Delayed corneal haze after combined photorefractive keratectomy and corneal cross-linking in non-keratoconus patients.
Article in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo assess the incidence rate of corneal haze after combined simultaneous photorefractive keratectomy (PRK) and accelerated (10-min, 9 mW/cm
methodsThis is a retrospective cohort study on patients without keratoconus underwent simultaneous CXL-PRK. Uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), manifest refraction, corneal keratometry, and corneal haze were evaluated.
resultsIncluded were 92 eyes of 55 subjects with mean age of 31.42 ± 4.62 years and mean follow-up time of 13.83 ± 11.24 months (range: 6 to 46 months). Mean UCVA improved significantly from 1.06 ± 0.36 to 0.14 ± 0.17 logMAR after procedure (P = 0.01), but the mean BCVA worsened significantly from 0.02 ± 0.05 to 0.08 ± 0.11 logMAR (P = 0.01). Significant corneal haze occurred in 18 eyes (19.6%). Among them 11 eyes (61.1%) developed corneal haze in first postoperative year. The BCVA deteriorated in 83.3% (15/18) of hazy eyes while 63.5% (47.74) of eyes without haze formation did not have any change of BCVA (P < 0.001). The UCVA improved in majority of eyes with (88.9%, 16/18) or without (97.3%, 72/74) haze formation (P = 0.18). Densitometry analysis showed that the densest layer of cornea in eyes with haze was anterior layer at 10-12 periphery zone followed by anterior layer at 2 mm central zone.
conclusionNearly one-fifth of eyes develops significant corneal haze after CXL-PRK procedure. Despite of UCVA improvement, the loss of BCVA in eyes with corneal haze, suggests that CXL-PRK procedure should be approached with caution.
Indexed as
Identifiers
40875071What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.